Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liquan Hong

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
RSC Advances|October 21, 2024
Biomimetic nanoparticles with red blood cell membranes for enhanced photothermal and immunotherapy for tumorsLiquan Hong, Jingtao Ye, Yang Li, et al.
RSC Advances|July 19, 2023
Nanoparticle-based drug delivery systems targeting cancer cell surfacesLiquan Hong, Wen Li, Yang Li, et al.
Nature Communications|July 8, 2024
tRNA m<sup>1</sup>A modification regulate HSC maintenance and self-renewal via mTORC1 signalingHongna Zuo, Aiwei Wu, Mingwei Wang, et al.
Frontiers in Endocrinology|June 12, 2023
Causal relationship between circulating immune cells and the risk of type 2 diabetes: a Mendelian randomization studyJin Li, Qingmin Niu, Aiwei Wu, et al.
Briefings in Functional Genomics|April 30, 2024
Unveiling aging dynamics in the hematopoietic system insights from single-cell technologiesXinrong Jin, Ruohan Zhang, Yunqi Fu, et al.
Journal of Medical Virology|December 26, 2015
Epidemiologic study of human parvovirus B19 infection in East ChinaLahong Zhang, Chengsong Cai, Feng Pan, et al.
Journal of Clinical Pathology|November 16, 2017
Rapid diagnosis of pulmonary tuberculosis and detection of drug resistance by combined simultaneous amplification testing and reverse dot blotYiwen Chen, Lahong Zhang, Liquan Hong, et al.
Scientific Reports|January 31, 2026
TRMT6 mitigates susceptibility and progression of DSS-induced colitis multifacetedly via translational regulationXianli Zhang, Yanting Du, Yuefang Ye, et al.
Neuroimage|January 22, 2026
A Watershed Algorithm GUI for Personalized fMRI-guided rTMS TargetZi-Jian Feng, Ziyu Wei, Liquan Hong, et al.
Oncotargets and Therapy|May 27, 2016
miR-125b inhibited epithelial-mesenchymal transition of triple-negative breast cancer by targeting MAP2K7Liquan Hong, Feng Pan, Huifen Jiang, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
RSC Advances|October 21, 2024
Biomimetic nanoparticles with red blood cell membranes for enhanced photothermal and immunotherapy for tumorsLiquan Hong, Jingtao Ye, Yang Li, et al.
RSC Advances|July 19, 2023
Nanoparticle-based drug delivery systems targeting cancer cell surfacesLiquan Hong, Wen Li, Yang Li, et al.
Nature Communications|July 8, 2024
tRNA m<sup>1</sup>A modification regulate HSC maintenance and self-renewal via mTORC1 signalingHongna Zuo, Aiwei Wu, Mingwei Wang, et al.
Frontiers in Endocrinology|June 12, 2023
Causal relationship between circulating immune cells and the risk of type 2 diabetes: a Mendelian randomization studyJin Li, Qingmin Niu, Aiwei Wu, et al.
Briefings in Functional Genomics|April 30, 2024
Unveiling aging dynamics in the hematopoietic system insights from single-cell technologiesXinrong Jin, Ruohan Zhang, Yunqi Fu, et al.
Journal of Medical Virology|December 26, 2015
Epidemiologic study of human parvovirus B19 infection in East ChinaLahong Zhang, Chengsong Cai, Feng Pan, et al.
Journal of Clinical Pathology|November 16, 2017
Rapid diagnosis of pulmonary tuberculosis and detection of drug resistance by combined simultaneous amplification testing and reverse dot blotYiwen Chen, Lahong Zhang, Liquan Hong, et al.
Scientific Reports|January 31, 2026
TRMT6 mitigates susceptibility and progression of DSS-induced colitis multifacetedly via translational regulationXianli Zhang, Yanting Du, Yuefang Ye, et al.
Neuroimage|January 22, 2026
A Watershed Algorithm GUI for Personalized fMRI-guided rTMS TargetZi-Jian Feng, Ziyu Wei, Liquan Hong, et al.
Oncotargets and Therapy|May 27, 2016
miR-125b inhibited epithelial-mesenchymal transition of triple-negative breast cancer by targeting MAP2K7Liquan Hong, Feng Pan, Huifen Jiang, et al.
Pageof 2